Generalised Anxiety Disorder
6
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
16.7%
1 terminated out of 6 trials
66.7%
-19.8% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
CBT and the Neural Circuits of Anxiety
A Neuro-Technological Intervention for Adolescents With GAD
A Non-randomized Controlled Trial Was Conducted to Observe the Improvement in the Level of HAMA in Patients With Generalized Anxiety Disorder During the 6-week Period of Oral Treatment With Chaihu Jia Longgu Muli Tang (Bupleurum Plus Dragon Bone and Oyster Shell Decoction) Combined With Sertraline.
Self-help Lifestyle Medicine for Generalized Anxiety Symptoms
INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1
Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety